Grimm K, Lehner A, Fernandez Rodriguez S, Orban M, et al. Conversion to everolimus in pediatric heart transplant recipients is a safe treatment option with an impact on cardiac allograft vasculopathy and renal function. Clin Transplant 2020 Dec 14:e14191. doi: 10.1111/ctr.14191.
PMID: 33315277